NCT01813487View on ClinicalTrials.gov

Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Chronic Hepatitis B
Interventions
DRUG

HBsAg vaccine with Entecavir

Trial Locations (1)

137 701

The Catholic University of Korea Seoul St. Mary's Hospital, Seoul

Sponsors

Lead Sponsor

Genexine, Inc.
All Listed Sponsors
lead

Genexine, Inc.

INDUSTRY

NCT01813487 - Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E | Biotech Hunter | Biotech Hunter